Encompass Health

Forecast & Rating13 analysts currently cover Encompass Health, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $148.17, about 22.5% upside from the current price of $120.92. Price targets are fairly clustered, pointing to relatively aligned views. Historically, about 64.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Encompass Health closely still see room for the stock to rise. Data as of Aug 10, 2026; for reference only and not investment advice.